These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 34576268)

  • 1. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.
    Du W; Gao Y; Liu L; Sai S; Ding C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates.
    Kantarcioglu AS; Yucel A; Vidotto V
    J Chemother; 2003 Jun; 15(3):296-8. PubMed ID: 12868560
    [No Abstract]   [Full Text] [Related]  

  • 4. Elucidating drug resistance in human fungal pathogens.
    Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
    Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal drug resistance mechanisms.
    Pemán J; Cantón E; Espinel-Ingroff A
    Expert Rev Anti Infect Ther; 2009 May; 7(4):453-60. PubMed ID: 19400764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.
    Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycotic Drugs and their Mechanisms of Resistance to
    Dahiya S; Sharma N; Punia A; Choudhary P; Gulia P; Parmar VS; Chhillar AK
    Curr Drug Targets; 2022; 23(2):116-125. PubMed ID: 34551694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Detection of Resistance to Azole Components.
    Posteraro B; Vella A; De Carolis E; Sanguinetti M
    Methods Mol Biol; 2017; 1508():423-435. PubMed ID: 27837519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.
    Juvvadi PR; Lee SC; Heitman J; Steinbach WJ
    Virulence; 2017 Feb; 8(2):186-197. PubMed ID: 27325145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Approaches for Combating
    Punia A; Choudhary P; Sharma N; Dahiya S; Gulia P; Chhillar AK
    Curr Drug Targets; 2022; 23(16):1465-1488. PubMed ID: 35748549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungicidal versus Fungistatic: what's in a word?
    Lewis JS; Graybill JR
    Expert Opin Pharmacother; 2008 Apr; 9(6):927-35. PubMed ID: 18377336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antifungal resistance development on the virulence of Candida species.
    Bohner F; Papp C; Gácser A
    FEMS Yeast Res; 2022 Apr; 22(1):. PubMed ID: 35325128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antifungal therapy for invasive fungal infections in children and adults.
    Hatipoglu N; Hatipoglu H
    Expert Rev Anti Infect Ther; 2013 May; 11(5):523-35. PubMed ID: 23627858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on antifungal resistance in Aspergillus and Candida.
    Arendrup MC
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.
    Beardsley J; Halliday CL; Chen SC; Sorrell TC
    Future Microbiol; 2018 Aug; 13(10):1175-1191. PubMed ID: 30113223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.